Related Experiment Video
Updated: Jul 13, 2026

Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling
Published on: March 20, 2018
Targeting carcinogen metabolism by dietary cancer preventive compounds
1Center for Cancer Prevention Research, Department of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ 08854, USA.
Abstract:
Prevention is one of the most important and promising strategies to control cancer. Many dietary bioactive compounds, mostly phytochemicals, have been found to decrease the risk of carcinogenesis. Modulating the metabolism and disposition pathways of carcinogens represents one of the major mechanisms by which dietary compounds prevent carcinogenesis. In the present review, the specific molecular targets of dietary compounds within carcinogen metabolism, including various enzymes and transporters and their regulatory signaling pathways, are briefly reviewed. The expression of phase I enzymes, which presumably mostly activate carcinogens, is mainly regulated by xenobiotics sensing nuclear receptors such as AhR, CAR, PXR, and RXR. On the other hand, phase II enzymes catalyze the conjugations of carcinogens and generally are transcriptionally controlled by the Nrf2/ARE signaling pathways. The Nrf2/ARE signaling pathway, which regulates the expression of many detoxifying enzymes, is a major target of dietary compounds. The final excretion of carcinogens and their metabolites is mediated by phase III transporters, which share many regulatory mechanisms with phase I/II enzymes. Indeed, the expression of metabolizing enzymes and transporters is often coordinately regulated. Besides transcriptional regulation, the activities of phase I/II enzymes and phase III transporters could be directly activated or inhibited by dietary compounds. Furthermore, genetic polymorphisms have profound effects on the individual response to dietary compounds. Finally, the effects of cancer prevention and the risk of carcinogenesis are determined by the network composed of known/unknown molecular targets and signaling pathways and its interaction with various xenobiotics, including carcinogens, drugs, and diet. With the rapid advances in the post genomic sciences, it could be possible to decipher this network and better predict the clinical outcomes of cancer prevention by dietary bioactive compounds.
Insights
Dietary compounds, particularly phytochemicals, can prevent cancer by modulating carcinogen metabolism. Key pathways like Nrf2/ARE and nuclear receptors are targeted, influencing enzyme and transporter activity for detoxification and excretion.
Area of Science:
- Molecular Biology
- Nutritional Science
- Cancer Prevention
Background:
- Cancer prevention is crucial, with dietary bioactive compounds showing promise.
- Phytochemicals are key dietary compounds that can reduce cancer risk.
- Modulating carcinogen metabolism is a primary mechanism for cancer prevention by diet.
Purpose of the Study:
- To review molecular targets of dietary compounds in carcinogen metabolism.
- To examine regulatory signaling pathways, enzymes, and transporters involved.
- To understand how diet influences cancer risk at a molecular level.
Main Methods:
- Review of scientific literature on carcinogen metabolism and dietary compounds.
- Analysis of molecular targets including xenobiotic receptors and signaling pathways (e.g., AhR, CAR, PXR, RXR, Nrf2/ARE).
- Examination of Phase I, II, and III enzymes and transporters involved in carcinogen disposition.
Main Results:
- Dietary compounds target nuclear receptors (AhR, CAR, PXR, RXR) regulating Phase I enzymes.
- The Nrf2/ARE pathway is a major target, controlling Phase II detoxifying enzymes.
- Phase III transporters are coordinately regulated with metabolizing enzymes, influencing excretion.
Conclusions:
- Dietary compounds influence carcinogen metabolism via multiple molecular targets and pathways.
- Genetic polymorphisms impact individual responses to dietary cancer prevention strategies.
- Understanding these complex networks is key to predicting clinical outcomes of dietary interventions.
Related Concept Videos
Cancer Prevention
Some...
Cancer Prevention
Some...
Mutagenicity and Carcinogenicity
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
